Erkut Borazanci

Collaboration Leads To Early Detection When The Cancer Is Easier To Treat

Affectionately Referred To As “Dr. B” By His Patients

Dr. Erkut Borazanci serves as Director of Oncology at HonorHealth Research Institute and is a board-certified medical oncologist specializing in gastrointestinal malignancies, particularly pancreatic cancer. He completed his medical degree and graduate training in biochemistry and molecular biology at Louisiana State University Health Sciences Center, followed by residency in internal medicine and fellowship in oncology. Dr. Borazanci is the principal investigator for several clinical trials, many of which are phase I and are first in human studies. He has a strong interest in pancreatic cancer and his research has been published in Nature, JAMA Oncology, Clinical Cancer Research, and the Oncologist, among others. HonorHealth Research Institute has closely worked with several collaborators (including the Seena Magowitz Foundation) to bring new and promising agents to offer as treatment options at HonorHealth Research Institute.

Honors & Awards

2016 – HonorHealth Physician Leadership Award: Citizenship and Community Service

2025 –  The Purple Pansies Bill Palmer Legacy Award

Certifications

Medical Oncology

Research Interests & Focus

Dr. Borazanci specializes in gastrointestinal malignancies, with a primary focus on pancreatic cancer and early-phase drug development. His research integrates molecular profiling, translational genomics, and innovative clinical trial design to advance targeted therapies for patients with advanced solid tumors.

Read The MediFind Article on its Top 10 Elite Pancreatic Cancer Experts.